An 8-year survey of strains identified in blood cultures in a clinical haematology unit

Clinical Microbiology and Infection

Volumn 20, Issue 1, 2014, Pages

  Bousquet, A ^a   Malfuson, J V ^a   Sanmartin, N ^a   Konopacki, J ^a   Macnab, C ^a   Souleau, B ^a   de Revel, T ^a   Elouennass, M ^b   Samson, T ^a   Soler, C ^a   Foissaud, V ^a   Martinaud, C ^a  

^a PERCY MILITARY HOSPITAL   (France)

^b Military   (Morocco)

Author keywords

Bacteraemia; Bone marrow; Haematology; Infections; Neutropenia; Transplantation

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; CEFTAZIDIME; COLISTIN; COTRIMOXAZOLE; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; TEICOPLANIN; TIMENTIN; VANCOMYCIN;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BLOOD CULTURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; COMMENSALISM; ENTEROBACTER; ENTEROCOCCUS; ESCHERICHIA COLI; FEBRILE NEUTROPENIA; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE COCCI; HEMATOLOGY; HUMAN; KLEBSIELLA; MAJOR CLINICAL STUDY; MYCOSIS; NEUTROPENIA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS HOMINIS; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS; STREPTOCOCCUS MITIS; STREPTOCOCCUS PNEUMONIAE;

BACILLI (CLASS); ENTEROBACTER; ESCHERICHIA COLI; FUNGI; KLEBSIELLA; NEGIBACTERIA; POSIBACTERIA; PSEUDOMONAS AERUGINOSA; SERRATIA; STAPHYLOCOCCUS; STAPHYLOCOCCUS EPIDERMIDIS; STENOTROPHOMONAS MALTOPHILIA;

BACTERAEMIA; BONE MARROW; HAEMATOLOGY; INFECTIONS; NEUTROPENIA; TRANSPLANTATION;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BLOOD; DRUG RESISTANCE, BACTERIAL; EPIDEMIOLOGICAL MONITORING; FEBRILE NEUTROPENIA; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HOSPITALS, MILITARY; HUMANS; MICROBIAL SENSITIVITY TESTS; RETROSPECTIVE STUDIES;

EID: 84890805768     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12294     Document Type: Article

References (31)

1. Bucaneve G, Micozzi A, Menichetti F et al. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Eng J Med 2005; 10: 977-987.
2. Feld R. Bloodstream infections in cancer patients with febrile neutropenia. Int J Antimicro A 2008; 32: 30-33.
3. Zinner SH. Changing epidemiology of infections in patients with neutropenia and cancer emphasis of Gram-positive and resistant bacteria. Clin Infect Dis 1999; 29: 490-494.
4. Elouennass M, Foissaud V, Trueba F et al. A 7-year survey of strains identified in blood cultures in a clinical haematology unit. Med Mal 2004; 34: 62-69.
5. Freifeld AG, Bow EJ, Sepkowitz KA et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. Clin Infect Dis 2011; 52: 427-431.
6. Mikulska M, Akova M, Averbuch D et al. Epidemiology of bacterial infections and antimicrobial resistance in haematological cancer patients. ECIL 2012: 4Th European Conference on infections in leukemia.
7. Swerdlow SH, Campo E, Haris NL et al. WHO Classification of tumours of hematopoietic and lymphoid tissues. Lyon: Edition International Agency for Research on Cancer, 2008
8. Agence nationale de sécurité du médicament et des produits de santé. Utilisation de préparation hospitalière dans la décontamination digestive sélective. Available from www.ansm.sante.fr (last accessed 12 October 2012).
9. Blot F, Nitenberg G, Chachaty E et al. Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures. Lancet 1999; 25: 1071-1077.
10. Cordonnier C, Herbrecht R, Buzyn A et al. Risk factors for Gram-negative bacterial infections in febrile neutropenia. Haematologica 2005; 90: 1102-1109.
11. Legrand M, Max A, Peigne V et al. Survival in neutropenic patients with severe sepsis or septic shock. Crit Care Med 2012; 40: 43-49.
12. Albrecht SJ, Fishman NO, Kitchen J et al. Reemergence of gram negative health care-associated bloodstream infections. Arch Intern Med 2006; 166: 1289-1294.
13. Luzzaro F, Ortisi G, Larosa M, Drago M, Brigante G, Gesu G. Prevalence and epidemiology of microbial pathogens causing bloodstream infections:results of the OASIS multicenter study. Diag Micro Infect Dis 2011; 69: 363-369.
14. Biedenbach DJ, Moet GJ, Jones RN. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the Sentry antimicrobial surveillance program. Diag Microbiol Infect Dis 2004; 50: 56-69.
15. Marra AR, Camargo L, Pignatari A et al. Nosocomial bloodstream infections in Brazilian hospitals: analysis of 2563 cases from a prospective nationwide surveillance study. J Clin Microbiol 2011; 49: 1866-1871.
16. Gupta A, Singh M, Singh H et al. Infections in acute myeloid leukemia: an analysis of 382 febrile episodes. Med Oncol 2010; 27: 1037-1045.
17. Cattaneo C, Quaresmini G, Casari S et al. Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution. J Antimicrob Chemother 2008; 61: 721-728.
18. Cattaneo C, Antoniazzi F, Casari S, Ravizzola G. P. aeruginosa bloodstream infections among haematological patients: an old or new question ? Ann Hematol 2012; 91: 1299-1304.
19. Elmaataoui A, Elghazouani M, Akwa EN et al. Blood isolates epidemiology in a clinical haematology department. Ann Biol Clin 2009; 67: 293-297.
20. Baskaran ND, Gan GG, Adeeba K, Sam IC. Bacteremia in patients with febrile neutropenia after chemotherapy at a university medical center in Malaysia. Int J Int Dis 2007; 11: 513-517.
21. Infectious diseases Society of America. Morbididy and mortality weekly report. Recommendations of CDC, ASBMT, October 2000.
22. Araoka H, Baba M, Yoneyama A. Risk factors for mortalitu among patients with Stenotrophomonas maltophilia bacteremia in Tokyo, Japan, 1966-2009. Eur J Clin Microbiol Infect Dis 2010; 29: 605-608.
23. Viscoli C, Castagnola E. Treatment of febrile neutropenia: what is new ? Curr Opin Infect Dis 2002; 15: 377-382.
24. Zahar JR, Farhat H, Chachaty E, Meshaka P, Antoun S, Nitenberg G. Incidence and clinical significance of anaerobic bacteraemia in cancer patients: a 6 year retrospective study. Eur Soc Clin Microbiol Infect Dis 2005; 11: 724-729.
25. Interscience conference on antimicrobial agents and chemotherapy. Available from www.icaac.org (last accessed 12 December 2012).
26. Sanmartin N, Martinaud C, Konopacki J et al. Interest for quantitative stool culture for patients with bone marrow transplantation: a retrospective study 2003-2010 in HIA Percy. Oral communication. Réunion interdisciplinaire de chimiothérapie antiinfectieuse, Novembre 2012, Paris.
27. Daw MA, Munnelly P, McCann SR, Daly PA, Falkiner FR, Keane CT. Value of surveillance cultures in the management of neutropenic patients. Eur J Clin Microbio Infect Dis 1988; 7: 742-747.
28. European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe, annual report 2010. Available from www.ecdc.europa.eu (last accessed 05 October 2013).
29. Observatoire national de l'épidémiologie de la résistance bactérienne aux antibiotiques. Available from www.onerba.org (last accessed 10 January 2013).
30. Decousser JW, Lamy B, Pina P, Allouch PY. Trends in antibiotic susceptibility of bloodstream pathogens in hospitalized patients in France, 1996 to 2007. Diag Micro Infect Dis 2010; 66: 292-300.
31. Paris-Nord Nosocomial Infection Prevention Coordinating Committee. Available from www.cclinparisnord.org (last accessed 20 January 13).